FIELD: medicine.
SUBSTANCE: for correction of endothelial dysfunction in experiment on rats dysfunction is modelled by preliminary sensitisation of animal with staphylococcus anatoxin in doze 0.1 ml subcutaneously. Then after 24 hours in the same place as anatoxin introduced is suspension of Staphylococcus aureus subcutaneously in dose 60 billions of microbial bodies in 1 ml. After that for following generalisation of infectious agent, daily massage of injection place is carried out. At this background introduced is macrolidal medication azithromycin intragastrically in dose 30 mg/kg/day.
EFFECT: method ensures activation of endothelial dysfunction correction.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR AZITHROMYCIN-BASED ENDOTHELIAL DYSFUNCTION CORRECTION IN EXPERIMENTAL REACTIVE VASCULITIS | 2009 |
|
RU2402333C1 |
JOSAMYCIN THERAPY FOR ENDOTHELIUM DYSFUNCTION CORRECTION ASSOCIATED WITH L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2007 |
|
RU2353369C1 |
MIDECAMYCIN-BASED CORRECTION MODE OF ENDOTHELIAL DYSFUNCTION ASSOCIATED WITH L-NAME-INDUCED NITROGEN OXIDE DEFICIENCY | 2007 |
|
RU2353370C1 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION WITH AZITHROMYCIN IN ADMA-LIKE GESTOSIS MODEL IN EXPERIMENT | 2012 |
|
RU2507595C2 |
METHOD FOR INCREASING SURVIVAL RATE OF ISOLATED SKIN PEDICLE FLAP IN ANIMALS HAVING REDUCED ANTIOXIDATION BACKGROUND | 2002 |
|
RU2283116C2 |
METHOD FOR EXPERIMENTAL AZYTHROMYCIN CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER IN ADMA-LIKE GESTOSIS MODELS | 2011 |
|
RU2462253C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION BY SOLUTION OF HOMOEOPATHIC DILUTIONS OF INTERLEUKIN-1 ANTIBODIES | 2011 |
|
RU2526150C2 |
METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION | 2011 |
|
RU2541166C2 |
MEDICATION FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2011 |
|
RU2536228C2 |
PHARMACEUTICAL COMPOSITION ELICITING ANTIBACTERIAL EFFECT | 2002 |
|
RU2223103C1 |
Authors
Dates
2010-09-27—Published
2009-10-29—Filed